View More Recent Stories

Oct 29, 2024 08:30AM Allogene Therapeutics (ALLO) Receives FDA Regenerative Medicine Advanced Therapy Designation for ALLO-316

Oct 22, 2024 04:06PM Artiva Biotherapeutics (ARTV) Appoints Alison Moore to its Board

Oct 17, 2024 06:44AM JPMorgan on Kyverna Therapeutics Inc (KYTX): 'armed with compelling clinical evidence to-date'

Sep 26, 2024 08:33AM Allogene Therapeutics (ALLO) to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases

Aug 7, 2024 04:04PM Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS

Jul 16, 2024 02:06PM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)

Jun 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)

View More Recent Stories